Xenon Pharmaceuticals, Inc. (XENE)
60.54
-0.23
(-0.38%)
USD |
NASDAQ |
Aug 24, 16:00
60.54
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals Debt to Equity Ratio : 0.0052 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0052 |
| March 31, 2026 | 0.0056 |
| December 31, 2025 | 0.0137 |
| September 30, 2025 | 0.0149 |
| June 30, 2025 | 0.0137 |
| March 31, 2025 | 0.0123 |
| December 31, 2024 | 0.0119 |
| September 30, 2024 | 0.0123 |
| June 30, 2024 | 0.0119 |
| March 31, 2024 | 0.0117 |
| December 31, 2023 | 0.0117 |
| September 30, 2023 | 0.0173 |
| June 30, 2023 | 0.0178 |
| March 31, 2023 | 0.0169 |
| December 31, 2022 | 0.0145 |
| September 30, 2022 | 0.0095 |
| June 30, 2022 | 0.01 |
| March 31, 2022 | 0.0152 |
| December 31, 2021 | 0.015 |
| September 30, 2021 | 0.013 |
| June 30, 2021 | 0.0136 |
| March 31, 2021 | 0.0115 |
| December 31, 2020 | 0.0193 |
| September 30, 2020 | 0.0043 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0048 |
| March 31, 2020 | 0.0871 |
| December 31, 2019 | 0.1788 |
| September 30, 2019 | 0.2202 |
| June 30, 2019 | 0.1984 |
| March 31, 2019 | 0.1897 |
| December 31, 2018 | 0.1454 |
| September 30, 2018 | 0.1335 |
| June 30, 2018 | 0.2294 |
| March 31, 2018 | 0.2413 |
| December 31, 2017 | 0.1893 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Sirona Biochem Corp. | -- |
| Psyence Biomedical Ltd. | -- |
| Aurinia Pharmaceuticals, Inc. | 0.1043 |
| enGene Therapeutics, Inc. | 0.1307 |
| Medicus Pharma Ltd. | -12.27 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.296B |
| Total Liabilities (Quarterly) | 53.38M |
| Shareholders Equity (Quarterly) | 1.242B |
| Current Ratio | 21.02 |
| Net Debt Paydown Yield | 0.01% |